Gardiquimod™
| Gardiquimod™ | Unit size | Cat. code | Docs | Qty | Price |
|---|---|---|---|---|---|
Imidazoquinoline compound |
500 µg 5 mg |
tlrl-gdqs |
TLR7 Agonist - Imidazoquinoline compound
Gardiquimod™ is an imidazoquinoline compound developed and manufactured by InvivoGen.
Similar to Imiquimod, Gardiquimod™ induces the activation of NF-κB in HEK293 cells expressing human or mouse TLR7.
Interestingly, Gardiquimod™ is more potent than Imiquimod.
Gardiquimod™ is specific for TLR7 when used at less than 1 µg/ml.
Back to the topSpecifications
Specificity: human/mouse TLR7 agonist
Working concentration: 0.1 - 3 µg/ml
CAS number: 1020412-43-4 (free base)
Solubility: 1 mg/ml in water
Back to the topContents
Gardiquimod™ is available in two quantities:
Catalog code :tlrl-gdqs
- 500 μg Gardiquimod™
- 1.5 ml of sterile endotoxin-free water
Catalog code :tlrl-gdq-5
- 5 mg Gardiquimod™
- 10 ml of sterile endotoxin-free water
Gardiquimod™ is provided lyophilized and shipped at room temperature.
Store at -20°C.
Lyophilized product is stable for 1 year at -20°C when properly stored.
Upon resuspension, prepare ailquots of Gardiquimod™ and store at -20°C for long term storage.
Resuspended product is stable for 6 months at -20°C.
Avoid repeated freeze-thaw cycles.